In alignment with its strategic focus on the healthcare continuum, Lonza expanded its Nutrition business by acquiring InterHealth Nutraceuticals, Inc., a leader in research, development, manufacturing and marketing of proprietary, value-added nutritional ingredients for use in dietary supplements, based in Benicia, CA (USA). IntraHealth’s UC-II ingredient, for example, is revolutionizing the joint-health field.
Lonza held the grand opening of its state-of-the-art pharmaceutical Drug Product Services laboratories in the Stücki Science Park Basel (CH). The new laboratory facility will focuses on formulation development, drug product analytical development and quality control. The addition of drug product development services to Lonza’s global offerings is the next part of the journey along the healthcare continuum, moving Lonza closer to its customers and their patients.